[Federal Register Volume 80, Number 158 (Monday, August 17, 2015)]
[Notices]
[Page 49252]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2015-20219]


-----------------------------------------------------------------------

DEPARTMENT OF HEALTH AND HUMAN SERVICES

National Institutes of Health


Notice of Kidney Interagency Coordinating Committee Meeting

SUMMARY: The Kidney Interagency Coordinating Committee (KICC) will hold 
a meeting on September 25, 2015, on the pharmacist's role in chronic 
kidney disease care. The meeting is open to the public.

DATES: The meeting will be held on September 25, 2015, 9 a.m. to 12 
p.m. Individuals wanting to present oral comments must notify the 
contact person at least 10 days before the meeting date.

ADDRESSES: The meeting will be held in the Natcher Conference Center on 
the NIH Campus at 9000 Rockville Pike, Bethesda, MD 20894.

FOR FURTHER INFORMATION CONTACT: For further information concerning 
this meeting, contact Dr. Andrew S. Narva, Executive Secretary of the 
Kidney Interagency Coordinating Committee, National Institute of 
Diabetes and Digestive and Kidney Diseases, 31 Center Drive, Building 
31A, Room 9A27, MSC 2560, Bethesda, MD 20892-2560, telephone: 301-594-
8864; FAX: 301-480-0243; email: [email protected].

SUPPLEMENTARY INFORMATION: The KICC, chaired by the National Institute 
of Diabetes and Digestive and Kidney Diseases (NIDDK), comprises 
members of the Department of Health and Human Services and other 
federal agencies that support kidney-related activities, facilitates 
cooperation, communication, and collaboration on kidney disease among 
government entities. KICC meetings, held twice a year, provide an 
opportunity for Committee members to learn about and discuss current 
and future kidney programs in KICC member organizations and to identify 
opportunities for collaboration. The September 25, 2015 KICC meeting 
will focus on the pharmacist's role in chronic kidney disease care.
    Any member of the public interested in presenting oral comments to 
the Committee should notify the contact person listed on this notice at 
least 10 days in advance of the meeting. Interested individuals and 
representatives or organizations should submit a letter of intent, a 
brief description of the organization represented, and a written copy 
of their oral presentation in advance of the meeting. Only one 
representative of an organization will be allowed to present; oral 
comments and presentations will be limited to a maximum of 5 minutes. 
Printed and electronic copies are requested for the record. In 
addition, any interested person may file written comments with the 
Committee by forwarding their statement to the contact person listed on 
this notice. The statement should include the name, address, telephone 
number and when applicable, the business or professional affiliation of 
the interested person. Because of time constraints for the meeting, 
oral comments will be allowed on a first-come, first-serve basis.
    Members of the public who would like to receive email notification 
about future KICC meetings should send a request to 
[email protected].

    Dated: August 4, 2015.
Camille M. Hoover,
Executive Officer, National Institute of Diabetes and Digestive and 
Kidney Diseases, National Institutes of Health.
[FR Doc. 2015-20219 Filed 8-14-15; 8:45 am]
 BILLING CODE 4140-01-P